ZYDUSLIFEPharmaceuticals
Zydus Lifesciences Ltd — Quarterly Results & Earnings
₹871.20
+0.00%
Profit Growth YoY40.92%Latest quarter
Sales Growth YoY16.92%Latest quarter
Sales CAGR 5Y10.27%5 year compound
Profit CAGR 5Y25.92%5 year compound
📋
Quarterly Performance
YoY Profit Growth+40.92%
🔥 Exceptional growth
YoY Sales Growth+16.92%
✅ Strong growth
OPM 5Y Average
25.73%Operating profit margin
EPS Growth 5Y
26.36%Interest Coverage
23.80Higher = safer debt servicing
ROE
21.21%ROCE
24.31%💡
Growth Analysis
Zydus Lifesciences Ltd reported YoY profit growth of 40.92% and revenue growth of 16.92% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 10.27% and profits at 25.92% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Zydus Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.